Shaws research 22/3/10 values RES at $4.04 DCF with a 75% risk discount to a 12 month target of $1.15. Previous target of 80c has been increased due to progress of the project.
Rated a buy with a speculative nature with the likelyhood of share price appreiation assuming completion of key milestones.
Research report is in PDF format so I cant copy and paste so will talk to the source about getting in a format that can be shared.
- Forums
- ASX - By Stock
- RES
- latest shaws research - $1.15
latest shaws research - $1.15
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RES (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online